Evidence map›Paper›PMID 27031095›Full record

ArticlePloS one2016

Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity.

Janin Chandra, Yan Miao, Natasha Romoff, Ian H Frazer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Immunotherapy for HPV associated cancer.Papillomavirus research (Amsterdam, Netherlands) · 2019
    Review
  16. Article
  17. Genital warts treatment: Beyond imiquimod.Human vaccines & immunotherapeutics · 2018
    Review
  18. Review
  19. Article
  20. Modulation of antigen presenting cell functions during chronic HPV infection.Papillomavirus research (Amsterdam, Netherlands) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Janin ChandraUniversity of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.
Yan MiaoUniversity of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.
Natasha RomoffUniversity of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.
Ian H FrazerUniversity of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland 4102, Australia.
Translational Research Institute · AUUniversity of Queensland · AU

Funding

Novel Interventions Against HPV-associated NeoplasiaU01CA141583 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F., MUNGER, KARL · 2009 to 2013
$3.8M
NCI NIH HHS 5U01CA141583NCI NIH HHS U01 CA141583
6 · The paper itself

Abstract

Antigen presenting cells (APCs) in skin can promote either antigen-specific effector functions or antigen tolerance, and thus determine clearance or persistence of cutaneous viral infections. Human papillomavirus (HPV) infections can persist in squamous epithelium in immunocompetent individuals, and some persisting HPV infections, particularly with HPV16, promote malignant epithelial transformation. Here, we investigate whether local expression of the HPV16 protein most associated with malignant transformation, HPV16-E7, affects the phenotype and function of APC subsets in the skin. We demonstrate an expanded population of Langerhans cells in HPV16-E7 transgenic skin with distinct cell surface markers which express immune-modulatory enzymes and cytokines not expressed by cells from non transgenic skin. Furthermore, HPV16-E7 transgene expression in keratinocytes attracts new APC subsets to the epidermis. In vivo migration and transport of antigen to the draining lymph node by these APCs is markedly enhanced in HPV16-E7 expressing skin, whereas antigen-processing, as measured by proteolytic cleavage of DQ-OVA and activation of T cells in vivo by APCs, is significantly impaired. These data suggest that local expression of HPV16-E7 in keratinocytes can contribute to persisting infection with this oncogenic virus, by altering the phenotype and function of local APCs.

Indexed as

AnimalsCell MovementCell Transformation, ViralDendritic CellsEpidermisEpithelial CellsHuman papillomavirus 16HumansKeratinocytesMiceMice, TransgenicNeoplasms, Squamous CellPapillomavirus E7 ProteinsSkin Neoplasmsoncogene protein E7, Human papillomavirus type 16Papillomavirus E7 Proteins

Identifiers

PMID27031095
PMCPMC4816461
OpenAlexW2317771600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.